The global pandemic combined with the continued regulatory limo in the United States has created significant turmoil in the market.
Turmoil in market
For example, Charlotte’s Web, one of best known publicly traded CBD brands, has seen its stock price fall from more than $21 a share in 2019 to less than 40 cents a share today. Another prominent public company in the sector, CV Sciences, has seen a similar decline, falling from a pre pandemic high of more than $6 a share in late 2018 to 37 cents a share today.
But market research firm Grandview Research forecasts future strong growth, indicating that the underlying consumer demand remains strong, even if stock traders have soured on the category. If brands like those above and others can weather the storm, they stand to reap the benefits of a global CBD market that the research firm forecasts will hit $22 billion by 2030, with 16.8% CAGR in the intervening years.
Product innovation has continued as well. New delivery forms such as gummies are making a splash, and new suppliers are continuing to debut in the market.
NutraIngredients-USA has assembled an influential set of speakers for a webinar to be broadcast on Oct. 20, 2022 at 11 am Central time. The panel will delve into the questions of the future of the market, where the latest science is going, and what’s in store on the regulatory front. Will FDA EVER move off the dime?
Webinar panel
The panel for this FREE EVENT will consist of:
Steven Hoffman, director, Compass Natural Marketing, a Boulder, CO-based full-service public relations, marketing, brand communications, and strategic business development agency specializing in the $300-billion LOHAS – or Lifestyles of Health and Sustainability – market. He is former Education Director for Natural Products Expo East and West, the world’s largest natural and organic products trade expositions. Steve also served as Editorial Director of New Hope Network’s highly respected natural products trade publishing division, including the Natural Foods Merchandiser magazine, and he is a current contributor to New Hope Network’s IdeaXchange. Hoffman also served as National Marketing Director and Rocky Mountain Regional Sales Manager for Arrowhead Mills, now a leading division of the Hain-Celestial Group. Currently, he serves as Editor of Let’s Talk Hemp, a weekly business newsletter and news website.
Sibyl Swift, PhD, is the Vice President for Scientific & Regulatory Affairs for cbdMD and the co-chair of cbdMD Therapeutics. She was also recently appointed as a Member of the Board of Directors for cbdMD. As VP for cbdMD, she directs the company’s research partnerships, clinical trials, advises on regulatory matters, guides new product development and R&D, and provides guidance on good manufacturing practices. Prior to joining cbdMD, Dr. Swift was the Senior Vice President for Scientific & Regulatory Affairs at the Natural Products Association (NPA). In that role, Dr. Swift was responsible for the development and implementation of the association’s education, regulatory, and compliance programs. Before joining NPA, Dr. Swift was the Associate Director for Research and Strategy within the US Food and Drug Administration’s (FDA) Office of Dietary Supplement Programs. Dr Swift earned her Ph.D. in nutrition and M.S. in exercise physiology at Texas A&M University. She is currently a member of the American Society for Nutrition, the ComPLI committee with the Natural Products Association, and the Science and Regulatory Affairs Committee for the Council for Federal Cannabis Regulation.
Jonathan Miller, a member in charge of Frost Brown Todd’s Washington DC office, helped found and serves as general counsel of the U.S. Hemp Roundtable (and its sister organization, the U.S. Hemp Authority). He has served as a leading advocate the industry on hemp and CBD legislation in Congress and in dozens of state legislatures. A recovering politician (the Democrat was elected twice as Kentucky’s State Treasurer), Jonathan has worked across the aisle with leading hemp champions such as U.S. Senate Minority Leader Mitch McConnell on critical legislation, including the 2014 and 2018 Farm Bills. Now he spends his time working with Congress, the White House, the USDA, FDA and DEA to promote policies that advance the industry. In acknowledgment of his accomplishments, the National Law Journal named Jonathan to its inaugural class of “Trailblazers” among government relations professionals and Politico labeled him a “Power Player” on hemp issues on Capitol Hill. Miller is a Harvard Law School graduate.
Registration
For more information and to register for this FREE EVENT, scheduled for 11:00 Central time on Oct. 20, 2002, click here.
